or Try an Advanced Search...

    Immune Response Stocks List

    Symbol Grade Name % Change
    CVM F Cel-Sci Corporation -6.06
    ACET F Adicet Bio, Inc. 1.20
    RAPT D RAPT Therapeutics, Inc. 6.05
    ZTS D Zoetis Inc. -4.00
    ANIX A Anixa Biosciences, Inc. -1.09
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Cancer Biotechnology Disease Immune System Medicine Antigen Chimeric Antigen Receptor Clinical Medicine Immunology Adoptive Cell Transfer Allergies Amines Animal Health Anti Infectives Antibodies Autoimmunity Biopharmaceutical Blood Test Cancer Immunotherapy Cancer Treatment

    Related ETFs - A few ETFs which own one or more of the above listed Immune Response stocks.

    Symbol Grade Name Weight
    PAWZ D ProShares Pet Care ETF 9.84
    MOO D Market Vectors Agribusiness ETF 7.8
    PINK D Simplify Health Care ETF 4.86
    VNSE C Natixis Vaughan Nelson Select ETF 4.73
    PPH D Market Vectors Pharmaceutical ETF 4.63
    View all Immune Response ETFs...
    Compare ETFs
    Compare MOO to PPH Compare MOO to VNSE Compare VNSE to PPH

        Immune Response Stocks Recent News

        Date Stock Title
        Nov 4 ZTS Zoetis Inc. (ZTS) Q3 2024 Earnings Call Transcript
        Nov 4 ZTS Zoetis Stock Slumps, Though Fluffy's Drugmaker Beats And Raises
        Nov 4 ZTS Zoetis' Blockbuster Quarter: Earnings Soar, New Markets Captured, and 2024 Outlook Raised
        Nov 4 ZTS Compared to Estimates, Zoetis (ZTS) Q3 Earnings: A Look at Key Metrics
        Nov 4 ZTS Zoetis Inc. 2024 Q3 - Results - Earnings Call Presentation
        Nov 4 ZTS Zoetis (ZTS) Q3 Earnings and Revenues Beat Estimates
        Nov 4 ZTS Zoetis lifts full-year guidance amid strength at companion animal unit
        Nov 4 ZTS Zoetis: Q3 Earnings Snapshot
        Nov 4 ZTS Zoetis beats Q3 top and bottom line estimates, raises FY revenue guidance
        Nov 4 ZTS Zoetis Announces Third Quarter 2024 Results
        Nov 3 ZTS Wall Street Week Ahead
        Nov 3 ZTS Zoetis (NYSE:ZTS) Declares $0.432 Dividend and Unveils Innovative Vetscan OptiCell for Market Growth
        Nov 1 ZTS Zoetis Q3 2024 Earnings Preview
        Nov 1 ZTS Stocks to watch next week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S
        Nov 1 ZTS PAHC Stock Likely to Gain From Its Latest Acquisition of Zoetis
        Oct 31 ANIX Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024
        Oct 30 ZTS Gear Up for Zoetis (ZTS) Q3 Earnings: Wall Street Estimates for Key Metrics
        Oct 29 ZTS Earnings Preview: Zevra Therapeutics (ZVRA) Q3 Earnings Expected to Decline
        Oct 29 ZTS Should We Be Delighted With Zoetis Inc.'s (NYSE:ZTS) ROE Of 47%?
        Oct 29 ZTS Zoetis Gears Up to Report Q3 Earnings: What's in the Offing?
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Cancer Biotechnology Disease Immune System Medicine Antigen Chimeric Antigen Receptor Clinical Medicine Immunology Adoptive Cell Transfer Allergies Amines Animal Health Anti Infectives Antibodies Autoimmunity Biopharmaceutical Blood Test Cancer Immunotherapy Cancer Treatment
        Immune Response

        Immune response is the body's natural defense against foreign substances, such as bacteria, viruses, and toxins. It is a complex process involving the recognition of foreign substances, the production of antibodies to fight them, and the destruction of the foreign substances. The immune system is made up of a network of cells, tissues, and organs that work together to protect the body from disease.

        Browse All Tags